Consensus Novo Nordisk A/S

Equities

NOVO B

DK0062498333

Market Closed - Nasdaq Copenhagen Other stock markets 10:59:31 2024-05-31 am EDT			5-day change	1st Jan Change
927.3 ^DKK	+1.13%		-0.16%	+32.83%

May. 31	Zealand Pharma Secures EU Panel Backing for Severe Hypoglycemia Treatment	MT
May. 30	Danish Government Implements Stricter Subsidy Rules for Diabetes Drugs	MT

Evolution of the average Target Price on Novo Nordisk A/S

Price target over the last 5 years

History of analyst recommendation changes

c280984c9cb1e7f0517a4d45d7d3cf10.35FzebniezqeMUBiTiIk_Q--rSfe4YtrgB3CLBYG-Cw.ttA9KferFmLwVgslKRZ8kFDs6RO_0tMSwlb1VFBxgWXy4xId3pAPYOpEcA~c32d24ab0c1a6bc5cca8bd469ed09a43

Analyst Recommendations on Novo Nordisk A/S

NOVO NORDISK : Buy rating by Goldman Sachs	May. 30	ZD
NOVO NORDISK : Deutsche Bank reaffirms its Buy rating	May. 28	ZD
NOVO NORDISK : JP Morgan reiterates its Buy rating	May. 24	ZD
Social Buzz: Wallstreetbets Stocks Mixed Pre-Bell; Hims & Hers Health to Advance, AMC Entertainment to Decline	May. 21	MT
NOVO NORDISK : UBS sticks Neutral	May. 15	ZD
NOVO NORDISK : JP Morgan reaffirms its Buy rating	May. 14	ZD
NOVO NORDISK : UBS reaffirms its Neutral rating	May. 14	ZD
Stifel Lifts Novo Nordisk PT, Keeps Buy Recommendation	May. 14	MT
NOVO NORDISK : Stifel raises its target price	May. 14	CF
Novo Nordisk Reportedly Asked by US Senator to Reduce Prices of Ozempic, Wegovy Drugs in US	May. 13	MT
Novo Nordisk Plans First Bond Sale in 2 Years	May. 13	MT
NOVO NORDISK : Berenberg reiterates its Neutral rating	May. 08	ZD
Novo Nordisk Seeks More Time to Address US Sen. Bernie Sanders' Questions on Drug Pricing	May. 07	MT
NOVO NORDISK : Barclays remains its Buy rating	May. 07	ZD
NOVO NORDISK : UBS sticks Neutral	May. 06	ZD
Novo Nordisk: share price falls, analyst adjusts target	May. 03	CF
NOVO NORDISK : DZ Bank sticks Neutral	May. 03	ZD
NOVO NORDISK : Stifel lowers target slightly	May. 03	CF
NOVO NORDISK : Buy rating from Deutsche Bank	May. 03	ZD
Novo Nordisk drops 5% after rival Amgen teases weight-loss drug data	May. 03	RE
NOVO NORDISK : JP Morgan gives a Buy rating	May. 03	ZD
NOVO NORDISK : Q1 beat; guidance upgrade but sentiment nonetheless dampened by price reductions	May. 02
NOVO NORDISK : Gets a Buy rating from Barclays	May. 02	ZD
NOVO NORDISK : UBS gives a Neutral rating	May. 02	ZD
NOVO NORDISK : JP Morgan gives a Buy rating	May. 02	ZD

More recommendations

Analysts' Consensus

Sell

Buy

Mean consensus

OUTPERFORM

Number of Analysts

Last Close Price

927.3 DKK

Average target price

917.2 DKK

Spread / Average Target

-1.09%

High Price Target

1,120 DKK

Spread / Highest target

+20.78%

Low Price Target

530 DKK

Spread / Lowest Target

-42.84%

Consensus detail

Consensus revision (last 18 months)

Analysts covering Novo Nordisk A/S

GOLDMAN SACHS	James Quigley
DEUTSCHE BANK RESEARCH	Emmanuel Papadakis
JPMORGAN	Richard Vosser
Stifel Nicolaus
UBS	Jo Walton
BERENBERG	Kerry Holford
DZ BANK	Elmar Kraus
BARCLAYS	Emily Field
alphavalue	Abhishek Raval
JEFFERIES	Peter Welford
BERNSTEIN RESEARCH	Florent Cespedes
BMO Capital
Cantor Fitzgerald
TD Cowen
ODDO BHF
Berenberg Bank
CREDIT SUISSE	Lorenzo Biasio
Morgan Stanley
BNP Paribas Exane
JPMorgan Chase
Guggenheim
Bryan, Garnier & Co.
Deutsche Bank Securities
DEUTSCHE BANK	Emmanuel Papadakis
Liberum Capital
KEPLER CHEUVREUX	David Evans
HSBC	Stephen McGarry
INDEPENDENT RESEARCH	Tobias Gottschalt
BANK OF AMERICA (BOFA)	Sachin Jain

Ratings for Novo Nordisk A/S

Trading Rating

Investor Rating

ESG Refinitiv

More Ratings

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar